R. Veeramachaneni

发表

Confirmation of oxidative stress and fatty acid disturbances in two further Papillon–Lefèvre syndrome families with identification of a new mutation

J. Quiles, M. Battino, M. Ramirez-Tortosa, 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma

B. Schmidt, K. Ono, N. Scheff, 2018, Neuropharmacology.

Characterization of neutrophil function in Papillon‐Lefèvre syndrome

N. Thakker, H. Roberts, I. Chapple, 2016, Journal of leukocyte biology.

Changes in Abundance of Oral Microbiota Associated with Oral Cancer

Adam B. Olshen, Brian L. Schmidt, Patricia M. Corby, 2014, PloS one.

Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy

Thomas Walker, R. Shaw, I. Hampson, 2018, Scientific Reports.

Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects

A. Sikora, Wangjie Yu, H. Skinner, 2021, Journal for ImmunoTherapy of Cancer.

How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum

W. Reardon, A. Collins, J. Clayton-Smith, 2011, European Journal of Human Genetics.

Esomeprazole enhances the effect of ionizing radiation to improve tumor control

M. Bonnen, T. Pandita, C. Coarfa, 2021, Oncotarget.

Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis

D. Albertson, B. Schmidt, B. Huey, 2014, BMC Cancer.

University of Birmingham Characterization of neutrophil function in PapillonLefèvre syndrome

N. Thakker, H. Roberts, I. Chapple, 2020 .

Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response

N. Putluri, V. Putluri, A. Sikora, 2022, Journal for ImmunoTherapy of Cancer.

Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis

D. Albertson, B. Schmidt, B. Huey, 2014, BMC Cancer.

Oncogenes overexpressed in metastatic oral cancers from patients with pain: potential pain mediators released in exosomes

N. H. Tu, D. Albertson, B. Schmidt, 2020, Scientific Reports.

Abstract 4885: Changes in abundance of oral microbiota associated with oral cancer

D. Albertson, A. Olshen, B. Schmidt, 2014 .

Footwear‐Generated Dynamic Biomechanical Manipulation and Perturbation Training for Chronic Nonspecific Low Back Pain

M. Bartels, Se won Lee, R. Veeramachaneni, 2018, PM & R : the journal of injury, function, and rehabilitation.

Abstract 5174: PEGylated liposomal doxorubicin improves oral cancer response to radio-immunotherapy

K. Ghaghada, A. Annapragada, A. Sikora, 2023, Cancer Research.

Characterization of neutrophil function in Papillon‐Lefèvre syndrome

N. Thakker, H. Roberts, I. Chapple, 2016, Journal of leukocyte biology.

Analysis of head and neck carcinoma progression reveals novel and relevant stage-speci(cid:420)c changes associated with immortalisation and malignancy

J. Ragoussis, Thomas Walker, I. Hampson, 2019 .

TP53 gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV-associated oral squamous cell carcinoma

S. Cao, X. Chen, A. Osman, 2023, Journal for ImmunoTherapy of Cancer.